Malignant Peritoneal Neoplasm Recruiting Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03126812Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian CancerTreatment